• Designs for Health
  • Deerland Enzymes & Probiotics
  • Everwell Health
  • Revision Skincare / Goodier Cosmetics
  • Santa Cruz Nutritionals
  • SunMed

Jawwad A. Akhtar


Mr. Akhtar is a Principal at RoundTable, working with the Pharmaceuticals & Consumer Health team. In this role, he focuses on the identification, evaluation, and execution of new platform investments and portfolio company add-on transactions.

Mr. Akhtar currently works with RoundTable’s investments in Deerland Probiotics & Enzymes, Revision Skincare / Goodier Cosmetics, Salter Labs, and Santa Cruz Nutritionals. He was also involved with the firm’s investments in Aspen Surgical, Beaver-Visitec International, CorePharma, Excelsior Medical, and Vesta prior to their successful exits.

Before joining RoundTable, Mr. Akhtar was an Analyst in the healthcare group at Robert W. Baird & Co.


  • Principal, 2019 – Present
  • Vice President, RoundTable, July 2015 – June 2019
  • Senior Associate, RoundTable, July 2013 – July 2015
  • Associate, RoundTable, July 2011 – July 2013
  • Healthcare Investment Banking, Robert W. Baird & Co., July 2009 – July 2011


  • Bachelor’s degree in Finance and Bachelor’s degree in Accountancy, University of Illinois, 2009